LiverTox drug record: Ivermectin (last updated April 9, 2021) (2021)

Peer-Reviewed Study · LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, U.S. National Institute of Diabetes and Digestive and Kidney Diseases · April 9, 2021

LiverTox: Clinical et al., 2021-04-09: The U.S. federal drug-induced-liver-injury reference entry for ivermectin, scoring it a likelihood D: a possible but rare cause of mild, self-limited liver injury. It records one published case and notes that aminotransferase elevations in COVID-19 trials were no more frequent on ivermectin than on placebo or comparator.

Ivermectin has not been associated with acute liver failure or chronic liver injury.

LiverTox: Clinical et al., 2021-04-09: The U.S. federal drug-induced-liver-injury reference entry for ivermectin, scoring it a likelihood D: a possible but rare cause of mild, self-limited liver injury. It records one published case and notes that aminotransferase elevations in COVID-19 trials were no more frequent on ivermectin than on placebo or comparator. Study type: review.